The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

Biogen expects revenue from new launches to exceed its current sales by 2028 and does not feel the need to chase additional ...

Pharma Digs in on Changes It Wants From Trump Administration By Deena Beasley SAN FRANCISCO (Reuters) - The pharmaceutical industry, grappling with new government limits on drug prices ...

(Reporting by Deena Beasley in Los Angeles; additional reporting by Bhanvi Satija in Bengaluru; Editing by Caroline Humer and Bill Berkrot) ...